{
  "ptid_time": "072_S_4103_2012-08-21",
  "img_path": "/data/qiuhui/data/adni/images/072_S_4103/2012-08-21/t1.nii.gz",
  "img_finding": "Image findings: hippocampal volume measures 5,505 mm³, 27.2% below the reference mean. With a Z-score of -2.65 (0.4th percentile), this represents significant atrophy; whole brain volume measures 836,914 mm³, 22.5% below the reference mean. With a Z-score of -2.92 (0.2th percentile), this represents significant atrophy. ",
  "text_data": "Age is 71.9 years. Gender is Male. Education: 20 years. MMSE: 28.0. MoCA: 26.0. Logical Memory: 12.0. APOEε4 alleles: 0.0. ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The hippocampal and whole brain volumes show significant atrophy (Z-scores < -2.5, <5th percentile), which is strongly suggestive of neurodegeneration. However, cognitive scores (MMSE 28, MoCA 26) remain within normal ranges, indicating preserved function despite structural decline.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (structural decline without functional impairment meets MCI criteria, though some may argue preclinical AD given biomarker severity).  \n\n**Confidence:** **Medium** (high confidence in neurodegeneration, but MCI diagnosis is less certain due to normal cognition—could also represent preclinical AD).  \n\n*Note:* APOE4-negative status reduces but doesn’t eliminate AD risk. Follow-up biomarkers (e.g., amyloid PET, CSF) would clarify etiology.",
  "timestamp": "2025-07-26T09:17:38.211298"
}